Protein phosphatase PP4 is overexpressed in human breast and lung tumors

Cell Research

Volumn 18, Issue 9, 2008, Pages 974-977

  Wang, Bo ^a   Zhao, Ailian ^b   Sun, Lingling ^c   Zhong, Xueyan ^d   Zhong, Jianing ^a   Wang, Haibo ^a   Cai, Minhua ^a   Li, Jing ^a   Xu, Yi ^a   Liao, Ji ^a   Sang, Jianli ^c   Chowdhury, Dipanjan ^e   Pfeifer, Gerd P ^d   Yen, Yun ^d   Xu, Xingzhi ^a  

^a CAPITAL NORMAL UNIVERSITY   (China)

^b PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^c BEIJING NORMAL UNIVERSITY   (China)

^d CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN PHOSPHATASE 4;

BREAST TUMOR; DRUG ANTAGONISM; ENZYMOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; LUNG TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; ENZYME INHIBITORS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; PHOSPHOPROTEIN PHOSPHATASES;

EID: 51049111624     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2008.274     Document Type: Letter

References (11)

1. Moorhead GB, Trinkle-Mulcahy L, Ulke-Lemee A. Emerging roles of nuclear protein phosphatases. Nat Rev Mol Cell Biol 2007; 8:234-244.
2. Toyo-oka K, Mori D, Yano Y, et al. Protein phosphatase 4 catalytic subunit regulates Cdk1 activity and microtubule organization via NDEL1 dephosphorylation. J Cell Biol 2008; 180:1133-1147.
3. Mourtada-Maarabouni M, Kirkham L, Jenkins B, et al. Functional expression cloning reveals proapoptotic role for protein phosphatase 4. Cell Death Differ 2003; 10:1016-1024.
4. Shui JW, Hu MC, Tan TH. Conditional knockout mice reveal an essential role of protein phosphatase 4 in thymocyte development and pre-T-cell receptor signaling. Mol Cell Biol 2007; 27:79-91.
5. Mihindukulasuriya KA, Zhou G, Qin J, Tan TH. Protein phosphatase 4 interacts with and down-regulates insulin receptor substrate 4 following tumor necrosis factor-alpha stimulation. J Biol Chem 2004; 279:46588- 46594.
6. Gingras AC, Caballero M, Zarske M, et al. A novel, evolutionarily conserved protein phosphatase complex involved in cisplatin sensitivity. Mol Cell Proteomics 2005; 4:1725-1740.
7. Wu HI, Brown JA, Dorie MJ, Lazzeroni L, Brown JM. Genomewide identifcation of genes conferring resistance to the anticancer agents cisplatin, oxaliplatin, and mitomycin C. Cancer Res 2004; 64:3940-3948.
8. Rabik CA, Dolan ME. Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev 2007; 33:9-23.
9. Chowdhury D, Xu X, Zhong X, et al. A PP4-phosphatase complex dephosphorylates gamma-H2AX generated during DNA replication. Mol Cell 2008; 31:33-46.
10. Chowdhury D, Keogh MC, Ishii H, Peterson CL, Buratowski S, Lieberman J. gamma-H2AX dephosphorylation by protein phosphatase 2A facilitates DNA double-strand break repair. Mol Cell 2005; 20:801-809.
11. Stange DE, Radlwimmer B, Schubert F, et al. High-resolution genomic profling reveals association of chromosomal aberrations on 1q and 16p with histologic and genetic subgroups of invasive breast cancer. Clin Cancer Res 2006; 12:345-352.